Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers.

Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...

Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

According to new research from Fox Chase Cancer Center, radiation therapy administered before surgery rarely produces ...

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

New NCCN guidelines recognize the utility of MammaPrint for guiding anthracycline therapy selection in HR+/HER2- early-stage ...

In a rare and complex surgical procedure, a senior surgeon from Nishtar Hospital successfully removed a massive 18.5-kilogram ...

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic ...

One of the persistent challenges in precision oncology is the fact that most advanced cancers are complex and highly individualized. A recent ...

GTB-5550 represents GT Biopharma's third NK cell engager advancing toward clinical development, targeting B7-H3, a protein prevalent across breast, lung, ovarian, pancreatic, prostate, bladder, and ...